← Prev in month ← Prev in thread
Next in thread → Next in month →

FW: SAF - Statement of Use by BAML

From
Isaiadis, Stavros <>
Date
2013-06-19T12:12:46+00:00
ID
6C421ABEB42E2644B491B69E2541CCE136F57160@smtp_mail.bankofamerica.com
Thread
FW: SAF - Statement of Use by BAML
Hi all,

 

Please find approval from Bank of America Merrill Lynch primary representative below.

 

Thanks and regards,

Stavros

 

 

From: Barbir, Abbie

Sent: 19 June 2013 13:11

To: Isaiadis, Stavros; 

Cc: Chet Ensign

Subject: RE: SAF - Statement of Use by BAML

 

Stavros

Approved

Please forward to the SAF list

 

Regards

Abbie Barbir

BofA 

 

From: Isaiadis, Stavros

Sent: Wednesday, June 19, 2013 5:43 AM

To: 

Cc: Barbir, Abbie; Chet Ensign

Subject: SAF - Statement of Use by BAML

 

Hi all,

Bank of America Merrill Lynch has successfully implemented the OASIS Symptoms Automation Framework (SAF) Version 1.0 Committee Specification 02 (http://docs.oasis-open.org/saf/saf/v1.0/cs02/saf-v1.0-cs02.doc)
 approved 30 January 2013, in accordance with all of the conformance clauses contained in Section 7 of the specification.
This did not include interoperation with multiple, independent implementations.

 

Abbie, as BAML’s primary OASIS representative, can you please respond with a statement of approval
 regarding the above implementation.

 

Thanks and regards,

Stavros

This message, and any attachments, is for the intended recipient(s) only, may contain information that is privileged, confidential and/or proprietary and subject to important terms and conditions available at http://www.bankofamerica.com/emaildisclaimer.   If you are not the intended recipient, please delete this message.
← Prev in month ← Prev in thread
Next in thread → Next in month →